Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

Active Ankylosing Spondylitis Clinical Trial

Official title:
A Multicenter, Randomized, Double-blind, Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

Status Recruiting

Clinical Trial Summary

This clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05814939
Study type	Interventional
Source	Jiangsu vcare pharmaceutical technology co., LTD
Contact	Xiaojuan Lai
Phone	15358160458
Email	lai_xiaojuan@vcarepharmatech.com
Status	Recruiting
Phase	Phase 2
Start date	April 26, 2023
Completion date	April 23, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03357471` - Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease	Phase 3
Recruiting	`NCT04876781` - Korean Post-marketing Surveillance for Xeljanz XR
Recruiting	`NCT05212051` - Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active AS	Phase 2
Completed	`NCT05407246` - Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis	Phase 2